Publicaciones en colaboración con investigadores/as de KU Leuven (15)

2021

  1. Neuroserpin inclusion bodies in a fenib yeast model

    Microorganisms, Vol. 9, Núm. 7

2019

  1. Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP”

    Journal of Cystic Fibrosis, Vol. 18, Núm. 2, pp. 212-220

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

2017

  1. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study

    Intensive Care Medicine, Vol. 43, Núm. 4, pp. 509-518

  2. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

  3. European Respiratory Society guidelines for the management of adult bronchiectasis

    European Respiratory Journal, Vol. 50, Núm. 3

2015

  1. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia

    BMC Microbiology, Vol. 15, Núm. 1, pp. 1-10

2014

  1. Antiprotozoan lead discovery by aligning dry and wet screening: Prediction, synthesis, and biological assay of novel quinoxalinones

    Bioorganic and Medicinal Chemistry, Vol. 22, Núm. 5, pp. 1568-1585

  2. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Journal of Hepatology

2011

  1. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

    Clinical Microbiology and Infection, Vol. 17, Núm. 12, pp. 1859-1867

2008

  1. Combined inactivation of the Candida albicans GPR1 and TPS2 genes results in avirulence in a mouse model for systemic infection

    Infection and Immunity, Vol. 76, Núm. 4, pp. 1686-1694

2007

  1. Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)

    Clinical Infectious Diseases, Vol. 44, Núm. 10, pp. 1289-1297

2004

  1. Protein-protein interactions governing septin heteropentamer assembly and septin filament organization in Saccharomyces cerevisiae

    Molecular Biology of the Cell, Vol. 15, Núm. 10, pp. 4568-4583

2002

  1. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests

    Journal of Antimicrobial Chemotherapy, Vol. 49, Núm. 2, pp. 289-300

1996

  1. First example of A 4-amino-1,2,4,6-thiatriazine 1,1-dioxide derivative

    Heterocycles, Vol. 43, Núm. 10, pp. 2199-2204